Atomo Diagnostics Ltd: Results of 2024 Annual General Meeting Update
Atomo Diagnostics Ltd: Proposed issue of securities - AT1
Atomo Diagnostics Ltd: Results of 2024 Annual General Meeting
Atomo Diagnostics Ltd: 2024 Annual General Meeting - MD & CEO Address
Atomo Diagnostics Ltd: Chair's Address to Shareholders
Atomo Diagnostics Ltd: Withdrawal of Resolutions at 2024 Annual General Meeting
Atomo Diagnostics Ltd: Atomo secures Australian order for supply of HIV Self-Tests
Atomo Diagnostics Ltd: Annual General Meeting Webinar
Atomo Diagnostics Ltd: Quarterly Activities Report and Appendix 4C
Atomo Diagnostics Ltd: Atomo Investor Webinar Presentation
Atomo Diagnostics Ltd: Atomo Secures $2.44m Grant to Develop Syphilis Test
Atomo Diagnostics Ltd: 2024 Notice of Annual General Meeting
Atomo Diagnostics Ltd: Atomo Investor Webinar Presentation
Atomo Diagnostics Ltd: 2024 Appendix 4G and Corporate Governance Statement
Atomo Diagnostics Ltd: FY24 Results Presentation
Atomo Diagnostics Ltd: 2024 Appendix 4E and Annual Report
Atomo Diagnostics Ltd: Quarterly Activities Report and Appendix 4C
Atomo Diagnostics Ltd: Atomo Investor Webinar Presentation
Atomo Diagnostics Ltd: Change of Director's Interest Notice - John Kelly
Atomo Diagnostics Ltd: Notification of cessation of securities - AT1
No Data
No Data